Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type

Rapid inactivation of Ebola virus (EBOV) is crucial for high-throughput testing of clinical samples in low-resource, outbreak scenarios. The EBOV inactivation efficacy of Buffer AVL (Qiagen) was tested against marmoset serum (EBOV concentration of 1 × 10(8) 50% tissue culture infective dose per mill...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Microbiol
Main Authors: Smither, Sophie J., Weller, Simon A., Phelps, Amanda, Eastaugh, Lin, Ngugi, Sarah, O'Brien, Lyn M., Steward, Jackie, Lonsdale, Steve G., Lever, Mark S.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2015
Fag:
Virology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4572529/
https://ncbi.nlm.nih.gov/pubmed/26179307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01449-15
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker